drugset / Trial / NCT05567068

Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

NCT05567068

Phase 2 Completed 54 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

Statins exert numerous pleiotropic effects including anti-inflammatory, antioxidant properties, endothelial function improvement, and immunomodulation independent of their basic lipid-lowering properties.

Timeline

Start
2023-02-01
Primary completion
2025-06-01
Completion
2025-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 80 mg
Background Mesalamine Small molecule 1 g